U.S. scientists at Stanford University have apparently come up with a way to use tobacco to ‘grow’ key components for a new cancer vaccine. The vaccine could be used to bring down one form of lymphoma.

“They are using the plants as factories for an antibody chemical specific to the cells which cause follicular B-cell lymphoma, a type of non-Hodgkin's lymphoma.” (Source: bbc.com)

FRIDAY, July 18 (HealthDay News) -- The prevalence of mantle cell lymphoma, an aggressive form of non-Hodgkin lymphoma, is increasing, and most patients are diagnosed with advanced stages of the disease, notes a study by researchers at the University of Texas M.D. Anderson Cancer Center.

Mantle cell lymphoma is a fast-growing, incurable cancer of the immune system, characterized by cancer cells that may be in the lymph nodes, spleen, bone marrow, blood or gastrointestinal system.

TUESDAY, June 24 (HealthDay News) U.S. researchers say they've spotted an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer.

In experiments with mice, researchers at the National Jewish Medical and Research Center, Denver, found that the B-cell receptor on the surface of B-cells can cooperate with the MYC oncogene to accelerate the development of lymphomas. They also found that disrupting signals from the B-cell receptor can inhibit tumor growth.

SATURDAY, May 31 (HealthDay News) -- People who survived Hodgkin lymphoma as children have an increased risk of developing and dying from another cancer or cardiovascular disease as adults, according to a new report.

The treatment for Hodgkin -- chemotherapy and radiation -- may help drive these increased risks, according to the researchers.